Abstract
In the context of managed care, cost-containment strategies lead to the establishment of procedures aimed at reducing the expense of medication.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G.E. Simon, M. Von Korff, and J.H. Heiligenstein, 1996, Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs. tricyclic antidepressants, JA MA, 275:1897–1902.
D.A. Sclar, L.M. Robison, and T.L. Skaer, 1995, Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine, and sertraline in a health maintenance organization, J Int Med Res, 23:95–412.
T. Croghan, T.J. Lair, L.E. Engelhart, and W.H. Crown, 1997, Effect of antidepressant therapy on health care utilization and costs in primary care, Psych Serv, 48:1420–1426.
W.H. Crown, T.R. Hylan, and L. Meneades, 1998, Antidepressant selection and use and health care expenditures: an empirical approach, PharmacoEconomics,13:435–448.
T.R. Hylan, W.H. Crown, and L. Meneades, 1998, SSRI and TCA antidepressant selection and health care costs: a multivariate analyses, J Affect Disord, 47:71–79.
G.E. Simon, and P. Fishman, 1998, Cost implications of initial antidepressant selection in primary care, PharmacoEconomics, 13:61–70.
P. Boyer, J.M. Danion, and J.C. Bisserbe, 1998, Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression: a six-month double blind study in a primary-care setting in France, PharmacoEconomics, 1998,13(1 Pt 2):157–69.
Effective Health Care Bulletin, 1993, The treatment of depression in primary care, 5:1–12.
F. Song, N. Freemantle, and T.A. Sheldon, 1994, Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability, BMJ, 306:683–687.
I.M. Anderson, and B.M. Tomenson, 1994, The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants, J Psychopharm, 8:238–249.
M. Hotopf, G. Lewis, and C. Normand, 1996, Are SSRIs a cost-effective alternative to tricyclics? B J Psych 168:404–09.
B. Jonsson, and P.E. Bebbington, 1994, What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment, B J Psych, 164:665–673.
M. Nuijten, M. Hardens, and E. Soutre, 1995, A markov process analysis comparing the cost-effectiveness of maintenance therapy with citalopram versus standard therapy in major depression, PharmacoEconomics, 8:159–168.
S.A. Montgomery, R.E. Brown, and M. Clark, 1996, Economic analysis of treating depression with nefazodone vs. imipramine, B J Psych, 168:768–71.
S.A. Woods, and J. Rizzo, 1996, Cost-effectiveness of antidepressants reassessed, B J Psych, 170:257–263.
A.O. Olufade, K.J. Gregor, and S.P. James, 1998, Efficacy vs. effectiveness: the generalizability of randomized controlled trials in depression, Intl Clin Psychopharm, in press.
K. Demytteanere, 1997, Compliance during treatment with antidepressants, J Affect Disord, 43:27–39.
A.L. Montejo, I. Gilaberte, and C. Fombellida, 1998, Patron de uso de los inhibidores de la recaptacion de serontonina y venlafaxina en la practica clinica, Actas Luso Espan de Neural Psiq, 26:75–82.
M. Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psych, 23:56–62.
R.F. Prien, and D.J. Kupfer, 1986, Continuation drug therapy for major depressive disorder: how long should it be maintained? Am J Psych, 143:18–23.
F.M. Quitkin, P. McGrath, and J.W. Stewart, 1996, Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch Gen Psych. 53:785–792.
J. Cabasés, L. Gaite, and J.M. Haro, 1996, Aproximación al coste de la esquizofreniaen España, XVI Jornadas de EconomÃa de la Salud, June.
D.R. Cox, 1972, Regression models and life tables (with discussion), J Roy Stat Soc, B34:187–220.
P.D. Allison, 1995, Survival Analysis Using the SAS System: A Practical Guide, Cary NC: The SAS Institute.
K.J. Gregor, J.M. Overage, S.J. Coons, and R. McDonald, 1994, Selective serotonin reuptake inhibitor dose titration in a naturalistic setting, Clin Therap, 16:306–315.
D. Thompson, D.P Buesching, K.J. Gregor, and G. Oster, 1996, Patterns of antidepressant use and their relations to costs of care, Amer J Manag Care, 2:1239–1246.
W.Z. Potter, M.V. Rudorfer, and H. Monji, 1991,The pharmacologic treatment of depression, N Engl J Med, 325:633–642.
J. Mintz, L.I. Mintz, and M.J. Arruda, 1992, Treatments of depression and the functional capacity to work, Arch Gen Psych, 49:761–768.
M. Maj, F. Veltro, and R. Pirozzi, 1992, Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study, Am J Psych, 149:795–800.
M.P. Alonso, F.J. Abajo, and J.J. Martinez, 1998, Evolucion del consumo de antidepresivos en Espana. Impacto de los inhibidores selectivos de la recaptacion de serotonina, Med Clin, 108:161–65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Crown, W.H., Hylan, T.R., Montejo, A.L., Sacristan, J.A., Gilaberte, I., Meneades, L. (1999). Antidepressant Use and Clinical and Economic Outcomes in a Primary Care Psychiatry Center in Spain. In: Guimón, J., Sartorius, N. (eds) Manage or Perish?. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4147-9_33
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4147-9_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6860-1
Online ISBN: 978-1-4615-4147-9
eBook Packages: Springer Book Archive